Status Epilepticus
What's New
Last Posted: Nov 13, 2022
- Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis
R Stevelink et al, EBiomedicine, November 11, 2022 - Monitoring the Burden of Seizures and Highly Epileptiform Patterns in Critical Care with a Novel Machine Learning Method.
Kamousi Baharan et al. Neurocritical care 2020 Oct - A longitudinal footprint of genetic epilepsies using automated electronic medical record interpretation.
Ganesan Shiva et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Aug - Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort.
Symonds Joseph D et al. Brain : a journal of neurology 2019 142(8) 2303-2318 - Translational Genomics in Neurocritical Care: a Review.
Myserlis Pavlos et al. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2020 Feb - What is the role of next generation sequencing in status epilepticus?
Guerrini Renzo et al. Epilepsy & behavior : E&B 2019 Jul - CLINGEN Actionability Report for Tuberous Sclerosis Complex (TSC)-TSC1, TSC2
ClinGen Actionability Working Group - Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel.
Wirrell Elaine C et al. Pediatric neurology 2017 Mar 6818-34.e3 - SCN1A testing for epilepsy: application in clinical practice.
- Status epilepticus
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: